ConductScience.org, home

Trial · NCT04939675

Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation

NCT04939675, Not applicable, Unknown, National Taiwan University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation. Trials, record NCT04939675. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04939675

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation
NCT number
NCT04939675
Status
Unknown
Phases
Not applicable
Enrollment
40 participants, estimated
Lead sponsor
National Taiwan University Hospital
Conditions
Epilepsy
Interventions
Zonisamide 100mg, Levetiracetam 500mg, LamoTRIgine 50mg
First posted
2021-06-25
Last updated
2021-06-25

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMini-Mental State Examination12 weeks
The Mini-Mental State Examination is a common analysis of cognitive function, with a score range from 0 to 30, and higher score indicates a better performance of cognition. We hypothesized that differences after ASM intervention will have a difference score of 4 in comparison to the observational group.
SecondaryPattern changes in electroencephalography12 weeksChanges in electroencephalography, including presence or absence of epileptiform discharges or power of slow(theta and delta) waves will be documented.
SecondaryNeuropsychiatric Inventory Questionnaire12 weeks
Neuropsychiatric Inventory Questionnaire measures behavior and emotional abnormality, which are rated within a domain in terms of both frequency (1=rarely, less than once per week; 2=sometimes, about once per week; 3=often, several times per week; and 4=very often, once or more per day) and severity (1=mild; 2=moderate; 3=severe), thus yielding a composite symptom domain score (frequency × severity) ranging from 0 (absence of behavioral symptoms) to 144 points (maximum severity of behavioral symptoms).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04939675

GET https://conductscience.org/api/trials/v1/NCT04939675/registered